Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: F
Results 1 - 10 of 243 shown below
F 11782
J-M Barret, B T Hill and P L Olive
Characterization of DNA-strand breakage induced in V79 cells by F 11782, a catalytic inhibitor of topoisomerases
doi:10.1054/bjoc.2000.1514
F-SSCP
P Berggren, G Steineck, J Adolfsson, J Hansson, O Jansson, P Larsson, B Sandstedt, H Wijkström and K Hemminki
p53 mutations in urinary bladder cancer
doi:10.1054/bjoc.2001.1823
FAA
N J Panaro, N C Popescu, S R Harris and U P Thorgeirsson
Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells
doi:10.1038/sj.bjc.6690619
Fab
G L Scheffer, A W Reurs, B Jutten, S H W Beiboer, R van Amerongen, M Schoester, E A C Wiemer, H R Hoogenboom and R J Scheper
Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein
doi:10.1038/sj.bjc.6600159
Abstract | Full article | PDF
-
B Czarnocka, D Pastuszko, M Janota-Bzowski, A P Weetman, P F Watson, E H Kemp, R S McIntosh, M S Asghar, B Jarzab, E Gubala, J Wloch and D Lange
Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?
doi:10.1054/bjoc.2001.2015
Fab fragment
L M Pericleous, J Richards, A A Epenetos, N Courtenay-Luck and M P Deonarain
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1
advance online publication, 2005-11-01 00:00:00.000;
doi:10.1038/sj.bjc.6602847
Abstract | Full article | PDF
factor H
S Junnikkala, J Hakulinen, H Jarva, T Manuelian, L Bjørge, R Bützow, P F Zipfel and S Meri
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells
doi:10.1038/sj.bjc.6600614
Abstract | Full article | PDF
factor VIII
J R Goffin, O Straume, P O Chappuis, J-S Brunet, L R Bégin, N Hamel, N Wong, L A Akslen and W D Foulkes
Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
doi:10.1038/sj.bjc.6601195
Abstract | Full article | PDF
factors
M Boogaerts, B Coiffier and C Kainz
Impact of epoetin
on quality of life in patients with malignant diseasedoi:10.1038/sj.bjc.6600801
Abstract | Full article | PDF
faecal coprostanol
S K Panda, S C Chattoraj and S A Broitman
Correlation of neomycin, faecal neutral and acid sterols with colon carcinogenesis in rats
doi:10.1038/sj.bjc.6690476
faecal occult blood
M Nakajima, H Saito, Y Soma, T Sobue, M Tanaka and A Munakata
Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case–control study
doi:10.1038/sj.bjc.6601002
Abstract | Full article | PDF
-
D Weller, D Coleman, R Robertson, P Butler, J Melia, C Campbell, R Parker, J Patnick and S Moss
The UK colorectal cancer screening pilot: results of the second round of screening in England
advance online publication, 2007-11-20 00:00:00.000;
doi:10.1038/sj.bjc.6604089
Abstract | Full article | PDF
